Poland· PL-100001485
FANHDI
A von willebrand-faktor und faktor viii in kombination product containing zespół ludzkiego czynnika krzepnięcia viii i ludzkiego czynnika von willebranda, registered in Poland by Instituto Grifols S.A.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Von willebrand-faktor und faktor viii in kombination is registered in 11 of 19 countries.
Countries holding a registration under ATC B02BD06 (von willebrand-faktor und faktor viii in kombination), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Von willebrand-faktor und faktor viii in kombination · ATC B02BD06
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Zespół ludzkiego czynnika krzepnięcia VIII i ludzkiego czynnika von Willebranda
- Manufacturer
- Instituto Grifols S.A.
- Country
- Poland (PL)
- ATC code
- B02BD06
- ATC class
- von Willebrand-Faktor und Faktor VIII in Kombination
- Defined daily dose
- 1 TSD, E
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990783618
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B02BD06
Von willebrand-faktor und faktor viii in kombination, as other registers publish it.
- PolandFANHDIInstituto Grifols S.A.
- CzechiaFANHDIInstituto Grifols, S.A., Barcelona
- CzechiaFANHDIInstituto Grifols, S.A., Barcelona
- PolandFANHDIInstituto Grifols S.A.
- CzechiaFANHDIInstituto Grifols, S.A., Barcelona
- CzechiaFANHDIInstituto Grifols, S.A., Barcelona
- FinlandHaemateCSL Behring GmbH
- FinlandHaemateAbacus Medicine A/S
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/403abb39-b49e-47ba-80c9-71823df37573 GET /v1/drugs/403abb39-b49e-47ba-80c9-71823df37573?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań i infuzji",
"source": "urpl",
"strength": "50 j.m./ml; 500 j.m. + 60 j.m./ml; 600 j.m.",
"packaging": "05909990783618 ¦ Rp ¦ 46091\n1 fiol. proszku ¦ 1 amp.-strzyk. 10 ml + zestaw do sporządzania i podania",
"substance": "Ludzki VIII czynnik krzepnięcia krwi 500 j.m. + Ludzki czynnik von Willebranda 600 j.m.",
"common_name": "Zespół ludzkiego czynnika krzepnięcia VIII i ludzkiego czynnika von Willebranda",
"pl_product_id": "100001485",
"pozwolenie_nr": "07836",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about von willebrand-faktor und faktor viii in kombination.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.